Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene W Gerner

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Nutrition and Cancer|May 4, 2007
Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposisNatalia A Ignatenko, David G Besselsen, Upal K Basu Roy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trialAnne R Simoneau, Eugene W Gerner, Ray Nagle, et al.
Cancer Biology & Therapy|November 16, 2006
Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouseNatalia A Ignatenko, Hana Holubec, David G Besselsen, et al.
Molecular Carcinogenesis|December 6, 2005
The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesisHagit F Yerushalmi, David G Besselsen, Natalia A Ignatenko, et al.
Molecular Carcinogenesis|May 18, 2006
Role of polyamines in arginine-dependent colon carcinogenesis in Apc(Min) (/+) miceHagit F Yerushalmi, David G Besselsen, Natalia A Ignatenko, et al.
Cancer Biology & Therapy|November 8, 2007
Serial endoscopy in azoxymethane treated mice using ultra-high resolution optical coherence tomographyLida P Hariri, Ziping Qiu, Alexandre R Tumlinson, et al.
Cancer Growth and Metastasis|September 24, 2015
Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence TomographySusan LeGendre-McGhee, Photini S Rice, R Andrew Wall, et al.
British Journal of Cancer|January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trialMichael D Hogarty, David S Ziegler, Andrea Franson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 9, 2008
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trialFrank L Meyskens, Christine E McLaren, Daniel Pelot, et al.
Plos One|May 29, 2015
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaGiselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Nutrition and Cancer|May 4, 2007
Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposisNatalia A Ignatenko, David G Besselsen, Upal K Basu Roy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trialAnne R Simoneau, Eugene W Gerner, Ray Nagle, et al.
Cancer Biology & Therapy|November 16, 2006
Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouseNatalia A Ignatenko, Hana Holubec, David G Besselsen, et al.
Molecular Carcinogenesis|December 6, 2005
The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesisHagit F Yerushalmi, David G Besselsen, Natalia A Ignatenko, et al.
Molecular Carcinogenesis|May 18, 2006
Role of polyamines in arginine-dependent colon carcinogenesis in Apc(Min) (/+) miceHagit F Yerushalmi, David G Besselsen, Natalia A Ignatenko, et al.
Cancer Biology & Therapy|November 8, 2007
Serial endoscopy in azoxymethane treated mice using ultra-high resolution optical coherence tomographyLida P Hariri, Ziping Qiu, Alexandre R Tumlinson, et al.
Cancer Growth and Metastasis|September 24, 2015
Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence TomographySusan LeGendre-McGhee, Photini S Rice, R Andrew Wall, et al.
British Journal of Cancer|January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trialMichael D Hogarty, David S Ziegler, Andrea Franson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 9, 2008
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trialFrank L Meyskens, Christine E McLaren, Daniel Pelot, et al.
Plos One|May 29, 2015
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaGiselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, et al.
Pageof 9